Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies
Open Access
- 10 October 2020
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 538, 192-203
- https://doi.org/10.1016/j.bbrc.2020.10.012
Abstract
No abstract availableKeywords
Funding Information
- Bill and Melinda Gates Foundation
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
This publication has 85 references indexed in Scilit:
- HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope StructureImmunity, 2018
- Structural insights into the design of novel anti-influenza therapiesNature Structural & Molecular Biology, 2018
- Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidityProceedings of the National Academy of Sciences of the United States of America, 2012
- Cross-neutralization of influenza A viruses mediated by a single antibody loopNature, 2012
- A structural analysis of M protein in coronavirus assembly and morphologyJournal of Structural Biology, 2011
- Individual Variation in the Germline Ig Gene Repertoire Inferred from Variable Region Gene RearrangementsThe Journal of Immunology, 2010
- Few and Far Between: How HIV May Be Evading Antibody AvidityPLoS Pathogens, 2010
- Inference of Macromolecular Assemblies from Crystalline StateJournal of Molecular Biology, 2007
- Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape MutantsPLoS Medicine, 2006
- Ultra-potent Antibodies Against Respiratory Syncytial Virus: Effects of Binding Kinetics and Binding Valence on Viral NeutralizationJournal of Molecular Biology, 2005